Fresenius Medical Care Publishes Form 20-F for the Fiscal Year 2007
Posted on: Thursday, 28 February 2008, 15:00 CST
Fresenius Medical Care, the world's leading renal therapy company, today announced that it has filed the annual report 2007 under Form 20-F with the U.S. Securities and Exchange Commission (SEC).
The report is available at the SEC's website, www.sec.gov, as well as at the Company's website in the "Investor Relations" section: www.fmc-ag.com/internet/fmc/fmcag/agintpub.nsf/Content/SEC-Filings.
A hard copy of Fresenius Medical Care's annual report on Form 20-F, including the complete audited financial statements may be obtained from the Company free of charge upon request to the Company's Investor Relations department by e-mail at ir@fmc-ag.com.
Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,600,000 individuals worldwide. Through its network of 2,238 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 173,863 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).
For more information about Fresenius Medical Care, visit the Company's website at www.fmc-ag.com.
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
Source: Business Wire
Related Articles
- Emil Paganini, MD, Joins NxStage(R) As Critical Care Medical Advisor
- Complete Care Medical New COO Spearheads Debut of FDA Approved Products for New Urology Division
- Complete Care Medical Fills COO Position With Healthcare Industry Heavyweight
- Complete Care Medical, Inc. Announces Plans to Penetrate $3 Billion Per Year Urological Market
- Complete Care Medical Retains Grace Holdings Company As Strategic Consultant
- Take Control of Your Healthcare Needs With Choice and Convenience Through Complete Care Medical on MN1.Com
- Owens & Minor Announces Plans to Acquire McKesson's Acute-Care Medical and Surgical Supply Distribution Business
- Complete Care Medical, Inc. Approves Extension of Financing Commitment From TID Funding, Inc.
- Complete Care Medical, Inc. Announces Telecommunications Consolidation
- Complete Care Medical, Inc., Announces Agreement Between Diabetes Gold, Inc. And Patient Advocates for Prescription Drugs, Inc.
 |
 |
User Comments (0)
RSS Feeds